GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Apr 11, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on April 11, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing regarding share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — The company making the share repurchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK.
- April 2025 (date) — The period during which the transactions occurred.
FAQ
What was the exact number of GSK ordinary shares purchased?
The filing states that GSK purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
On what specific dates within April 2025 did the share purchases occur?
The filing indicates the report is for the month of April 2025 and mentions 'Date of pur' but does not list specific transaction dates.
What is the par value of GSK's ordinary shares?
The filing states the ordinary shares are of '31¼ pence each'.
Who is acting as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 11, 2025 regarding GSK plc (GLAXF).